Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseases
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Neurological symptoms of patients suffering from neurodegenerative diseases such as Alzheimer's dementia (AD), Parkinson's disease (PD), or amyotrophic lateral sclerosis (ALS) often worsen during infections. We assessed the disease‐modulating effects of recurrent systemic infections with the most frequent respiratory pathogen, Streptococcus pneumoniae, on the course of AD, PD, and ALS in mouse models of these neurodegenerative diseases [transgenic Tg2576 mice, (Thy1)‐[A30P]αSYN mice, and Tg(SOD1‐G93A) mice]. Mice were repeatedly challenged intraperitoneally with live S. pneumoniae type 3 and treated with ceftriaxone for 3 days. Infection caused an increase of interleukin‐6 concentrations in brain homogenates. The clinical status of (Thy1)‐[A30P]αSYN mice and Tg(SOD1‐G93A) mice was monitored by repeated assessment with a clinical score. Motor performance was controlled by the tightrope test and the rotarod test. In Tg2576 mice, spatial memory and learning deficits were assessed in the Morris water maze. In none of the three mouse models onset or course of the disease as evaluated by the clinical tests was affected by the recurrent systemic infections performed. Levels of α‐synuclein in brains of (Thy1)‐[A30P]αSYN mice did not differ between infected animals and control animals. Plaque sizes and concentrations of Aβ 1–40 and Aβ 1–42 were not significantly different in brains of infected and uninfected Tg2576 mice. In conclusion, onset and course of disease in mouse models of three common neurodegenerative disorders were not influenced by repeated systemic infections with S. pneumoniae, indicating that the effect of moderately severe acute infections on the course of neurodegenerative diseases may be less pronounced than suspected. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · cited 2×
“Chronic systemic IL-1 expression led to enhanced microglial activation and neurodegeneration in a model of Parkinson’s disease (Godoy et al., 2008). a-Synuclein has been linked with microglial activation in cultures and in brains of patients with PD (Croisier et al., 2005; Zhang et al., 2005).”
BackgroundInflammation in Neurodegenerative Disease—A Double-Edged Sword
Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235 · cited 1×
“The innate immune response can protect neurons, but its dysregulation can also be harmful for neuronal integrity and might trigger neurodegeneration (Kreutzberg, 1996; Nguyen et al., 2002; Wyss-Coray and Mucke, 2002; Iliev et al., 2004).”
BackgroundKawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053 · cited 1×
“As in brains of patients with AD, in Tg2576 mice Ab accumulates in plaques and as cerebral amyloid angiopathy in the brain (Kuo et al., 2000; Kawarabayashi et al., 2001).”
BackgroundSystemic infections and inflammation affect chronic neurodegeneration
Perry, V. H., Cunningham, C., & Holmes, C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2015 · Cited by 1,027
Cunningham, C., Wilcockson, D. C., Campion, S., Lunnon, K., & Perry, V. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2614-05.2005 · Cited by 768
Turner, M. R., Cagnin, A., Turkheimer, F. E., Miller, C. C. J., Shaw, C. E., Brooks, D. J., Leigh, P. N., & Banati, R. B. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.012 · Cited by 737 · cited 1×
“DOI: 10.1002/jnr.22270 ' 2009 Wiley-Liss, Inc. 2001; Raivich and Banati, 2004), is found in brains of patients with AD (Van Everbroeck et al., 2004; Kim and de Vellis, 2005), Parkinson’s disease (PD; McGeer et al., 1988; McGeer and McGeer, 2004), and amyotrophic lateral sclerosis (ALS; Turner et…”
BackgroundInfluentialCunningham, C., Campion, S., Lunnon, K., Murray, C. L., Woods, J. F. C., Deacon, R. M. J., Rawlins, J. N. P., & Perry, V. H. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.07.024 · Cited by 584 · cited 1×
“A systemic inflammatory challenge with endotoxin (LPS) in mice with prion disease led to enhanced brain inflammation, increased neurodegeneration, exacerbated cognitive and motor symptoms, and accelerated disease progression (Combrinck et al., 2002; Cunningham et al., 2005, 2008).”
BackgroundLayé, S., Parnet, P., Goujon, E., & Dantzer, R. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90197-x · Cited by 500
The impact of systemic infection on the progression of neurodegenerative disease
Perry, V. H., Newman, T. A., & Cunningham, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1032 · Cited by 428 · cited 1×
“VC 2009 Wiley-Liss, Inc. Key words: amyotrophic lateral sclerosis; Alzheimer’s disease; Parkinson’s disease; systemic infection; Streptococcus pneumoniae Neurological symptoms of patients suffering from neurodegenerative diseases often worsen during infections (Perry et al., 2003, 2007).”
BackgroundCroisier, E., Moran, L. B., Dexter, D. T., Pearce, R. K., & Graeber, M. B. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-14 · Cited by 414
Sheng, J. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00069-x · Cited by 388 · cited 1×
“After intraperitoneal or intracerebral administration of LPS to Tg2576 mice, both an increase in Ab brain concentrations (Sly et al., 2001; Sheng et al., 2003) and a reduction in cerebral Ab levels or cortical plaque burden (DiCarlo et al., 2001; Quinn et al., 2003; Herber et al., 2007) have been…”
MethodMollenhauer, B., Cullen, V., Kahn, I., Krastins, B., Outeiro, T. F., Pepivani, I., Ng, J., Schulz-Schaeffer, W., Kretzschmar, H. A., McLean, P. J., et al. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.06.004 · Cited by 382 · cited 1×
“These mice develop amyloid deposits in the brain at an age of 6 months and spatial memory deficits at an age of 9 months (Hsiao et al., 1996; Münch et al., 2003; Apelt et al., 2004).”
BackgroundSelf-citationMicroglia and inflammatory mechanisms in the clearance of amyloid β peptide
Rogers, J., Strohmeyer, R., Kovelowski, C. J., & Li, R. (2002) · Glia · doi:10.1002/glia.10153 · Cited by 381
Pott Godoy, M. C., Tarelli, R., Ferrari, C. C., Sarchi, M. I., & Pitossi, F. J. (2008) · Brain · doi:10.1093/brain/awn101 · Cited by 335 · cited 3×
“LPS injection in the substantia nigra was shown to exacerbate neurodegeneration and to accelerate and increase motor deficits in a rat 6-hydroxydopamine model of PD (Godoy et al., 2008).”
BackgroundNguyen, M. D., D'Aigle, T., Gowing, G., Julien, J.-P., & Rivest, S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4786-03.2004 · Cited by 248 · cited 6×
“Given the disease-modulating effect of systemic application of LPS in mouse models of ALS (Nguyen et al., 2004) and prion disease (Cunningham et al., 2005), our results are surprising.”
BackgroundMethodResultInfluentialPeripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease
Combrinck, M. I., Perry, V. H., & Cunningham, C. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00030-1 · Cited by 231 · cited 1×
“A systemic inflammatory challenge with endotoxin (LPS) in mice with prion disease led to enhanced brain inflammation, increased neurodegeneration, exacerbated cognitive and motor symptoms, and accelerated disease progression (Combrinck et al., 2002; Cunningham et al., 2005, 2008).”
Backgroundα-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia
Klegeris, A., Pelech, S., Giasson, B. I., Maguire, J., Zhang, H., McGeer, E. G., & McGeer, P. L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.11.013 · Cited by 227 · cited 2×
“In vitro, a-synuclein induced microglia-mediated neurotoxicity, with the mutated A30P a-synuclein being even more potent than the wild-type a-synuclein (Klegeris et al., 2008).”
BackgroundIntrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice
DiCarlo, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00292-5 · Cited by 223 · cited 1×
“…or intracerebral administration of LPS to Tg2576 mice, both an increase in Ab brain concentrations (Sly et al., 2001; Sheng et al., 2003) and a reduction in cerebral Ab levels or cortical plaque burden (DiCarlo et al., 2001; Quinn et al., 2003; Herber et al., 2007) have been observed.”
Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9)
Iliev, A. I., Stringaris, A. K., Nau, R., & Neumann, H. (2004) · The FASEB Journal · doi:10.1096/fj.03-0670fje · Cited by 192 · cited 1×
“The innate immune response can protect neurons, but its dysregulation can also be harmful for neuronal integrity and might trigger neurodegeneration (Kreutzberg, 1996; Nguyen et al., 2002; Wyss-Coray and Mucke, 2002; Iliev et al., 2004).”
BackgroundSelf-citationInflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease
Quinn, J. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00037-7 · Cited by 102
Endotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits
Liu, Y., Qin, L., Wilson, B., Wu, X., Qian, L., Granholm, A.-C., Crews, F. T., & Hong, J.-S. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2008.02.014 · Cited by 84 · cited 1×
“Repeated intraperitoneal injections of LPS caused motor behavioral deficits and loss of dopaminergic neurons in C57/BL6 mice (Liu et al., 2008).”
BackgroundVan Everbroeck, B., Dobbeleir, I., De Waele, M., De Leenheir, E., Lübke, U., Martin, J.-J., & Cras, P. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0879-2 · Cited by 66
Cited by
Microglia and neurodegeneration: The role of systemic inflammation
Cunningham, C. (2013) · Glia · doi:10.1002/glia.22350 · Cited by 769
Time to test antibacterial therapy in Alzheimer’s disease
Panza, F., Lozupone, M., Solfrizzi, V., Watling, M., & Imbimbo, B. P. (2019) · Brain · doi:10.1093/brain/awz244 · Cited by 161
Systemic inflammation and delirium: important co-factors in the progression of dementia
Cunningham, C. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390945 · Cited by 153
Ho, S.-C., Hsu, C.-C., Pawlak, C. R., Tikhonova, M. A., Lai, T.-J., Amstislavskaya, T. G., & Ho, Y.-J. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.022 · Cited by 65
Chouhan, J. K., Püntener, U., Booth, S. G., & Teeling, J. L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.760721 · Cited by 24
Metadata
- Authors
- Ebert, S., Goos, M., Rollwagen, L., Baake, D., Zech, W., Esselmann, H., Wiltfang, J., Mollenhauer, B., Schliebs, R., Gerber, J., & Nau, R.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2009-10-26
- Volume
- 88
- Issue
- 5
- Pages
- 1124-1136
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2011171397
- Cited by
- 17
- References
- 22
- FWCI
- 0.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.